Literature DB >> 30986866

Reduced Mannose-Binding Lectin-Associated Serine Protease (MASP)-1 is Associated with Disturbed Coagulation in Septic Shock.

Julie Brogaard Larsen1, Mathies Appel Laursen1, Christine Lodberg Hvas2, Kim Michael Larsen2, Steffen Thiel3, Anne-Mette Hvas1,4.   

Abstract

BACKGROUND: Activation of the complement system is part of the dysregulated immune response in sepsis. The mannose-binding lectin-associated serine proteases (MASP)-1 and -2 activate the lectin pathway of the complement system. Besides, these proteins can activate coagulation in vitro. However, the role of the lectin pathway proteins in the development of sepsis-related disseminated intravascular coagulation (DIC) is only sparsely investigated. AIM: This article investigates the association between lectin pathway proteins and coagulation disturbances in septic shock patients.
MATERIALS AND METHODS: We included 36 septic shock patients from the intensive care unit, Aarhus University Hospital, Denmark. Blood samples were obtained within 24 hours after admission (day 1), and subsequently on day 2 and day 3. Plasma concentrations of mannose-binding lectin (MBL), H-ficolin, M-ficolin, CL-L1, CL-K1, MASP-1, -2 and -3, MBL-associated proteins of 19 and 44 kDa as well as complement factor C3dg were assessed. Standard coagulation parameters, thrombin generation, thrombin-anti-thrombin (TAT) complex and pro-thrombin fragment 1 + 2 were measured. Sequential Organ Failure Assessment (SOFA) score, DIC score and 30-day mortality were assessed.
RESULTS: Reduced MASP-1 plasma concentration was associated with DIC score ≥5 (p = 0.02), impaired thrombin generation (p = 0.03) and lower plasma TAT complex levels (p = 0.03). No association was found between lectin pathway proteins and SOFA score or 30-day mortality.
CONCLUSION: Reduced MASP-1 concentrations were associated with impaired coagulation in septic shock patients. This indicates that increased MASP-1 activation and consumption is associated with the more severe coagulation disturbances in sepsis and points to a possible role for MASP-1 in sepsis-related DIC. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2019        PMID: 30986866     DOI: 10.1055/s-0039-1685140

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease.

Authors:  Nicholas R Medjeral-Thomas; Anne Troldborg; Annette G Hansen; Jack Gisby; Candice L Clarke; Maria Prendecki; Stephen P McAdoo; Eleanor Sandhu; Liz Lightstone; David C Thomas; Michelle Willicombe; Marina Botto; James E Peters; Matthew C Pickering; Steffen Thiel
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 8.786

2.  Efficacy of Etimicin Sulfate Combined with Cefotaxime Sodium in the Treatment of Patients with Septic Shock and Effect on Serum Inflammatory Factor Levels and Immune Function.

Authors:  Songqiang Pang; Yao Song; Jinqiang Yang; Sen Li; Yaqiang He; Gongtang Luo
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-06       Impact factor: 2.629

3.  Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study.

Authors:  Markus Korsholm Kristensen; Marco Bo Hansen; Martin Bruun Madsen; Cecilie Bo Hansen; Katrine Pilely; Ole Hyldegaard; Peter Garred
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

Review 4.  Association of Polymorphisms of MASP1/3, COLEC10, and COLEC11 Genes with 3MC Syndrome.

Authors:  Gabriela Gajek; Anna S Świerzko; Maciej Cedzyński
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.